The endoplasmic reticulum (ER) is crucial for protein synthesis and folding, and it senses cellular stress. When unfolded or misfolded proteins accumulate in the ER, it triggers the unfolded-protein response (UPR), a signaling pathway that helps the cell cope with stress. The UPR can initiate inflammation, and the coupling of these responses is fundamental in inflammatory diseases. Inflammation is the body's first response to infection or tissue injury, but chronic inflammation is harmful and contributes to diseases like diabetes and cardiovascular disease. Inflammation begins when immune cells detect pathogens or damage, leading to the release of inflammatory substances that alter cellular physiology. Cellular stress and excessive inflammation are linked to metabolic conditions such as obesity and diabetes. Recent studies show that the UPR and inflammation are interconnected through pathways involving reactive oxygen species (ROS), calcium release, and transcription factors like NF-κB and JNK. ER stress can lead to oxidative stress, which contributes to inflammation. The UPR activates pathways that regulate inflammation, including NF-κB and JNK, which are involved in inflammatory gene expression. The UPR also influences the acute-phase response, a process that involves the production of inflammatory proteins in the liver. ER stress can be triggered by metabolic factors, leading to chronic inflammation and disease. In obesity and type 2 diabetes, ER stress is linked to insulin resistance and inflammation. In atherosclerosis, ER stress in macrophages contributes to lesion formation. In neurodegenerative diseases, ER stress and protein aggregation are associated with inflammation and cell death. Therapeutic approaches targeting the UPR and inflammation, such as chemical chaperones and inhibitors of eIF2α dephosphorylation, show promise in reducing ER stress and inflammation. Understanding the complex interactions between the UPR and inflammation is crucial for developing effective treatments for metabolic and inflammatory diseases.The endoplasmic reticulum (ER) is crucial for protein synthesis and folding, and it senses cellular stress. When unfolded or misfolded proteins accumulate in the ER, it triggers the unfolded-protein response (UPR), a signaling pathway that helps the cell cope with stress. The UPR can initiate inflammation, and the coupling of these responses is fundamental in inflammatory diseases. Inflammation is the body's first response to infection or tissue injury, but chronic inflammation is harmful and contributes to diseases like diabetes and cardiovascular disease. Inflammation begins when immune cells detect pathogens or damage, leading to the release of inflammatory substances that alter cellular physiology. Cellular stress and excessive inflammation are linked to metabolic conditions such as obesity and diabetes. Recent studies show that the UPR and inflammation are interconnected through pathways involving reactive oxygen species (ROS), calcium release, and transcription factors like NF-κB and JNK. ER stress can lead to oxidative stress, which contributes to inflammation. The UPR activates pathways that regulate inflammation, including NF-κB and JNK, which are involved in inflammatory gene expression. The UPR also influences the acute-phase response, a process that involves the production of inflammatory proteins in the liver. ER stress can be triggered by metabolic factors, leading to chronic inflammation and disease. In obesity and type 2 diabetes, ER stress is linked to insulin resistance and inflammation. In atherosclerosis, ER stress in macrophages contributes to lesion formation. In neurodegenerative diseases, ER stress and protein aggregation are associated with inflammation and cell death. Therapeutic approaches targeting the UPR and inflammation, such as chemical chaperones and inhibitors of eIF2α dephosphorylation, show promise in reducing ER stress and inflammation. Understanding the complex interactions between the UPR and inflammation is crucial for developing effective treatments for metabolic and inflammatory diseases.